NCT06834932 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06827132 Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer Status RECRUITING Phase N/A
NCT06826677 REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER Status COMPLETED Phase N/A
NCT06824987 Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease Status RECRUITING Phase PHASE2
NCT06822543 A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer) Status RECRUITING Phase PHASE2
NCT06813781 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004 Status COMPLETED Phase PHASE1
NCT06812780 A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389 Status COMPLETED Phase PHASE1
NCT06796114 Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab Status RECRUITING Phase NA
NCT06795906 A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma Status COMPLETED Phase PHASE1
NCT06795022 First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours Status RECRUITING Phase PHASE1/PHASE2
NCT06792695 A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06764875 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer Status RECRUITING Phase PHASE3
NCT06764186 A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06759519 Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in Russia Status COMPLETED Phase N/A
NCT06757647 Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Status RECRUITING Phase PHASE2